The FDA issued recent updates regarding drugs that are currently in shortage or have been discontinued:
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Ethiodized Oil (Lipiodol) Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Isoniazid Oral Tablets (New – Discontinuation)
- Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
- Lidocaine HCl Topical Jelly (New – Discontinuation)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Lorazepam Injection, USP (New – Currently in Shortage)
- Magnesium Sulfate Injection (New – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (Updated – Currently in Shortage)
- Ropivacaine Hydrochloride injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Iodide I 131 Capsules (New – Discontinuation)
- Sodium Iodide I 131 Solution (New – Discontinuation)
- Stavudine Capsules (New – Discontinuation)
- Sterile Water (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
